ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2552

Design and Development of an Online Intervention for Lupus Self-Management Based on the Transtheoretical Model of Change

Sarah Gilman 1, Deborah Levesque 2, Carol Cummins 3, Daniel Wallace 4, Victoria Werth 5 and Patricia Davidson6, 1Wayfinder Health Strategies, Washington, DC, 2Pro-Change Behavior Systems, Providence, RI, 3Pro-Change Behavior Systems, Inc.,, Providence, 4Cedars-Sinai Medical Center/University California at Los Angeles, Los Angeles, CA, 5Corporal Michael J. Crescenz VAMC, Philadelphia, PA, USA and Department of Dermatology, University of Pennsylvania, Philadelphia, PA, USA, Philadelphia, PA, 6Lupus Foundation of America, Washington, DC

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: health behaviors and online resources, Lupus, Self-management, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: SLE – Clinical Poster III: Treatment

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: The Lupus Foundation of America is in Year 4 of a 6-year cooperative agreement with the Centers for Disease Control and Prevention to develop an online lupus self-management program based on the Transtheoretical Model of Change (the “stage model”). The program, Strategies to Embrace Living with Lupus Fearlessly (SELF), is a web-based intervention designed to help users adopt 4 key lupus self-management behaviors: 1) managing symptoms, 2) managing stress, 3) managing medications, and 4) working with a health care team. These behaviors were identified and operationally defined in year 3 of the cooperative agreement. We summarize the program design, as well as feedback from early users and engagement experts.

Methods: The intervention consists of 4 complementary components: 1) user assessments, 2) a web portal with stage-matched activities and information, 3) outbound text messages and emails to facilitate change and user engagement, and 4) a reporting tool to measure program utilization and outcomes.

The intake process consists of 4 modules, each focused on one of the 4 key behaviors. The modules provide feedback tailored to user responses to questions. After intake, users select a behavior to focus on, and a customized web portal becomes available. The portal includes stage-matched activities, a symptom tracker, a journal, information on the 4 key lupus self-management behaviors, and links to the Foundation’s National Resource Center on Lupus, Health Educators, and LupusConnect™ messaging boards for peer support. Participants can sign up for emails or texts with stage-matched tips and links to the portal activities.

Every two weeks, the program delivers a mini assessment to track changes in self-efficacy, and asks users to select the behavior they would like to focus on next. Every 90 days, the program administers a comprehensive assessment and a printable report summarizing data on lupus symptoms, self-management behaviors, and stage of change that can be shared with a provider.

5 individuals with lupus with diverse demographic characteristics recruited by the Lupus Foundation of America served as early program testers. Engagement experts also reviewed the program design and structure.  

Results: Feedback from early users and engagement experts was largely positive and used to refine the online program. Program development will be finalized by the Fall of 2019, at which time pilot testing will begin.

Conclusion: The SELF program is designed to provide a cohesive, tailored experience to help individuals with lupus manage their condition. This is the first program of its kind to deliver information and activities tailored to stage of change for four key behaviors for lupus self-management.


Disclosure: S. Gilman, None; D. Levesque, None; C. Cummins, None; D. Wallace, Amgen, 5, 9, Eli Lilly and Co, 9, Eli Lilly and Company, 5, EMD Merck Serono, 5, EMD Serono, 9, Pfizer, 5, 9; V. Werth, Biogen, 2, 5, Corbus Pharmaceuticals, 2, 9, University of Pennsylvania, 9; P. Davidson, None.

To cite this abstract in AMA style:

Gilman S, Levesque D, Cummins C, Wallace D, Werth V, Davidson P. Design and Development of an Online Intervention for Lupus Self-Management Based on the Transtheoretical Model of Change [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/design-and-development-of-an-online-intervention-for-lupus-self-management-based-on-the-transtheoretical-model-of-change/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/design-and-development-of-an-online-intervention-for-lupus-self-management-based-on-the-transtheoretical-model-of-change/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology